Does a diet high in carbohydrates increase your risk of dementia?

©2014, Mary Ann Liebert Inc. publishers

Even small increases in blood sugar caused by a diet high in carbohydrates can be detrimental to brain health. Recent reports in medical literature link carbohydrate calorie-rich diets to a greater risk for brain shrinkage, dementia and Alzheimer's disease, impaired cognition, and other disorders. David Perlmutter, MD, best-selling author of Grain Brain, explores this important topic in a provocative interview in Alternative and Complementary Therapies.

Dr. Perlmutter, a board-certified neurologist and fellow of the American College of Nutrition, has just been appointed Editor-in-Chief of a new peer-reviewed journal, Brain and Gut, that will debut in summer 2014. The journal will publish leading-edge research dedicated to exploring a whole systems approach to health and disease from the intimate relationship between the brain and the digestive systems.

In the interview "Rethinking Dietary Approaches for Brain Health," Dr. Perlmutter says, "We live with this notion that a calorie is a calorie, but at least in terms of brain health, and I believe for the rest of the body as well, there are very big differences between our sources of calories in terms of the impact on our health. Carbohydrate calories, which elevate blood glucose, are dramatically more detrimental to human physiology, and specifically to human health, than are calories derived from healthful sources of fat."

Dr. Perlmutter will explore how and cognitive function are linked to nutrition in his presentation, "The Care and Feeding of Your Brain," to be delivered at the 2014 Integrative Healthcare Symposium taking place now in New York City.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Putting dementia carers in control

Sep 18, 2014

Experts will explore how improved support and powers for people caring for loved-ones with dementia can improve quality of life for both patients and carers around the UK.

Lilly, AstraZeneca team up on Alzheimer's drug

Sep 16, 2014

Eli Lilly and Co. plans to pay up to $500 million to fellow drugmaker AstraZeneca as part of a collaboration to develop and sell a potential Alzheimer's disease treatment that is in the early stages of clinical testing.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

billpress11
not rated yet Feb 22, 2014
Personally, I think this article is right on target. Fats from vegetarian sources, especially nuts, probably do more good than harm. Carbohydrates, while we all need some, most of us consume much more than we what is good for us. That goes DOUBLE for sugars, we don't need any.